Article detail · 2012
Thrombin activatable fibrinolysis inhibitor and thrombin antithrombin III complex levels in patients with gastric cancer
YÖKSİS
OpenAlex
SJR Q1
JCR Q3
Citations 35
Top 10%
Percentile 92.8%
FWCI 3.54
- Year
- 2012
- Type
- article
Data source split
- YÖKSİS YÖKSİS article record
- YÖKSİS venue Tumor Biology
- Catalog match (ISSN) Tumor Biology
- OpenAlex OpenAlex enrichment (abstract, citations, topics)
Abstract
Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
35 citations
OpenAlex cited_by_count (cache / database)
10 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- Clinical and Prognostic Significance of Coagulation Assays in Gastric Cancer 2013
- Clinical and Prognostic Significance of Coagulation Assays in Gastric Cancer 2013
- Higher thrombin-antithrombin III complex levels may indicate severe acute pancreatitis. 2018
- Higher Thrombin-Antithrombin III Complex Levels May Indicate Severe Acute Pancreatitis.. 2018
- Higher Thrombin-Antithrombin III Complex Levels May Indicate Severe Acute Pancreatitis 2018
- Higher Thrombin-Antithrombin III Complex Levels May Indicate Severe Acute Pancreatitis 2018
- Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer 2012
- Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer 2012
- Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer. 2012
- Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer 2012